Fulcrum Therapeutics CEO Robert Gould's 2019 pay jumps 356% to $3.9M
Fulcrum Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Fulcrum Therapeutics reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, three executives at Fulcrum Therapeutics received on average a compensation package of $2.2M, a 74% increase compared to previous year.
Average pay of disclosed executives at Fulcrum Therapeutics
Robert J. Gould, Chief Executive Officer, received $3.9M in total, which increased by 356% compared to 2018. 80% of Gould's compensation, or $3.1M, was in option awards. Gould also received $300K in bonus and $478K in salary.
Owen Wallace, Chief Scientific Officer, received a compensation package of $1.6M. 67% of the compensation package, or $1.1M, was in option awards.
Bryan Stuart, Chief Operating Officer, earned $1.2M in 2019, a 27% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2020.